270 related articles for article (PubMed ID: 8161350)
21. Identification of amino acids required for the functional up-regulation of human dihydrofolate reductase protein in response to antifolate Treatment.
Skacel N; Menon LG; Mishra PJ; Peters R; Banerjee D; Bertino JR; Abali EE
J Biol Chem; 2005 Jun; 280(24):22721-31. PubMed ID: 15817466
[TBL] [Abstract][Full Text] [Related]
22. Drosophila dihydrofolate reductase mutations confer antifolate resistance to mammalian cells.
Affleck JG; Al-Batayneh KM; Neumann K; Cole SP; Walker VK
Eur J Pharmacol; 2006 Jan; 529(1-3):71-8. PubMed ID: 16325803
[TBL] [Abstract][Full Text] [Related]
23. A novel RNA silencing vector to improve antigen expression and stability in Chinese hamster ovary cells.
Hong WW; Wu SC
Vaccine; 2007 May; 25(20):4103-11. PubMed ID: 17428585
[TBL] [Abstract][Full Text] [Related]
24. Sp1 involvement in the 4beta-phorbol 12-myristate 13-acetate (TPA)-mediated increase in resistance to methotrexate in Chinese hamster ovary cells.
Noé V; Alemany C; Nicolás M; Ciudad CJ
Eur J Biochem; 2001 Jun; 268(11):3163-73. PubMed ID: 11389717
[TBL] [Abstract][Full Text] [Related]
25. Isolation and characterization of a dihydrofolate reductase gene mutation in methotrexate-resistant Drosophila cells.
Hao H; Tyshenko MG; Walker VK
Gene Expr; 1996; 6(4):231-9. PubMed ID: 9196078
[TBL] [Abstract][Full Text] [Related]
26. Methotrexate-induced overexpression of functional glucocorticoid receptors in Chinese hamster ovary cells.
Bellingham DL; Sar M; Cidlowski JA
Mol Cell Endocrinol; 1992 Feb; 83(2-3):153-71. PubMed ID: 1547909
[TBL] [Abstract][Full Text] [Related]
27. Use of the Escherichia coli chromosomal DHFR gene as selection marker in mammalian cells.
Asselbergs FA; Widmer R
J Biotechnol; 1995 Dec; 43(2):133-8. PubMed ID: 8562018
[TBL] [Abstract][Full Text] [Related]
28. Amplification of a polymorphic dihydrofolate reductase gene expressing an enzyme with decreased binding to methotrexate in a human colon carcinoma cell line, HCT-8R4, resistant to this drug.
Srimatkandada S; Schweitzer BI; Moroson BA; Dube S; Bertino JR
J Biol Chem; 1989 Feb; 264(6):3524-8. PubMed ID: 2914962
[TBL] [Abstract][Full Text] [Related]
29. Regulation of dihydrofolate reductase in human breast cancer cells and in mutant hamster cells transfected with a human dihydrofolate reductase minigene.
Cowan KH; Goldsmith ME; Ricciardone MD; Levine R; Rubalcaba E; Jolivet J
Mol Pharmacol; 1986 Jul; 30(1):69-76. PubMed ID: 3724746
[TBL] [Abstract][Full Text] [Related]
30. Methotrexate resistance in an in vivo mouse tumor due to a non-active-site dihydrofolate reductase mutation.
Dicker AP; Waltham MC; Volkenandt M; Schweitzer BI; Otter GM; Schmid FA; Sirotnak FM; Bertino JR
Proc Natl Acad Sci U S A; 1993 Dec; 90(24):11797-801. PubMed ID: 8265628
[TBL] [Abstract][Full Text] [Related]
31. Methotrexate metabolism in mutant Chinese hamster ovary cells lacking dihydrofolate reductase.
Joannon P; Whitehead VM; Rosenblatt DS; Vuchich MJ; Beaulieu D
Biochem Pharmacol; 1987 Apr; 36(7):1091-7. PubMed ID: 2436625
[TBL] [Abstract][Full Text] [Related]
32. Comparison of methotrexate resistance conferred by a mutated dihydrofolate reductase (DHFR) cDNA in two different retroviral vectors.
Takebe N; Nakahara S; Zhao SC; Adhikari D; Ural AU; Iwamoto M; Banerjee D; Bertino JR
Cancer Gene Ther; 2000 Jun; 7(6):910-9. PubMed ID: 10880023
[TBL] [Abstract][Full Text] [Related]
33. Transgenic mice expressing the tyr22 variant of murine DHFR: protection of transgenic marrow transplant recipients from lethal doses of methotrexate.
James RI; May C; Vagt MD; Studebaker R; McIvor RS
Exp Hematol; 1997 Nov; 25(12):1286-95. PubMed ID: 9357973
[TBL] [Abstract][Full Text] [Related]
34. [Mechanisms of development of resistance to methotrexate in choriocarcinoma cells].
Sakai K
Hokkaido Igaku Zasshi; 1986 Sep; 61(5):649-61. PubMed ID: 3781466
[TBL] [Abstract][Full Text] [Related]
35. Isolation and characterization of a mutant dihydrofolate reductase-thymidylate synthase from methotrexate-resistant Leishmania cells.
Arrebola R; Olmo A; Reche P; Garvey EP; Santi DV; Ruiz-Perez LM; Gonzalez-Pacanowska D
J Biol Chem; 1994 Apr; 269(14):10590-6. PubMed ID: 8144647
[TBL] [Abstract][Full Text] [Related]
36. The use of a wild-type dihydrofolate reductase-encoding cDNA as a dominant selectable marker and induction of expression by methotrexate.
Lo KM; Lynch CA; Gillies SD
Gene; 1992 Nov; 121(2):365-9. PubMed ID: 1446834
[TBL] [Abstract][Full Text] [Related]
37. Co-expression and amplification of dihydrofolate reductase cDNA and the Escherichia coli XGPRT gene in Chinese hamster ovary cells.
Ringold G; Dieckmann B; Lee F
J Mol Appl Genet; 1981; 1(3):165-75. PubMed ID: 6180118
[TBL] [Abstract][Full Text] [Related]
38. Role of the locus and of the resistance gene on gene amplification frequency in methotrexate resistant Leishmania tarentolae.
Kündig C; Leblanc E; Papadopoulou B; Ouellette M
Nucleic Acids Res; 1999 Sep; 27(18):3653-9. PubMed ID: 10471733
[TBL] [Abstract][Full Text] [Related]
39. Stimulation of dihydrofolate reductase promoter activity by antimetabolic drugs.
Eastman HB; Swick AG; Schmitt MC; Azizkhan JC
Proc Natl Acad Sci U S A; 1991 Oct; 88(19):8572-6. PubMed ID: 1833762
[TBL] [Abstract][Full Text] [Related]
40. Selective overproduction of human dihydrofolate reductase in a methotrexate-resistant human-mouse somatic cell hybrid.
Sastry KJ; Chan TS; Rodriguez LV
Biochem Biophys Res Commun; 1985 Oct; 132(2):795-803. PubMed ID: 4062946
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
